NEW INDANSULFAMIDNOE DERIVATIVES

FIELD: chemistry.SUBSTANCE: new indansulfamidnye derivatives or their pharmaceutically acceptable salt , such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfonamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VATANABE Toru, KOSASA Takasi, KHANADA Takakhisa, ISIKAVA Yukio, SAITO Minako, KITA Joiti, SORIMATI Keiiti, TANAKA Tosiaki, TERAMOTO Tetsuyuki, KADZUTA Yudzi, KHIGASIYAMA Khiroyuki
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VATANABE Toru
KOSASA Takasi
KHANADA Takakhisa
ISIKAVA Yukio
SAITO Minako
KITA Joiti
SORIMATI Keiiti
TANAKA Tosiaki
TERAMOTO Tetsuyuki
KADZUTA Yudzi
KHIGASIYAMA Khiroyuki
description FIELD: chemistry.SUBSTANCE: new indansulfamidnye derivatives or their pharmaceutically acceptable salt , such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfonamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, are characterized by the effect of improving seizure severity index (score) in a murine model of kindling.EFFECT: compound or salt thereof are assumed as a medicament for the treatment of epilepsy.8 cl, 10 tbl, 3 dwg, 31 ex Новые индансульфамидные производные, или их фармацевтически приемлемая соль, такие как N-[(1S)-2,2,5,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, N-[(1S)-2,2,4,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, (+)-N-(2,2,4,6,7-пентафтор-2,3-дигидро-1H-инден-1-ил)сульфамид, характеризуются действием улучшения индекса тяжести припадка (балл) на мышиной модели киндлинга. Таким образом, соединения или их соль предполагаются в качестве лекарственного средства для лечения эпилепсии. 8 н.п. ф-лы, 10 табл., 3 ил., 31 пр.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2619937C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2619937C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2619937C23</originalsourceid><addsrcrecordid>eNrjZFDwcw1X8PRzcfQLDvVxc_T1dPHzd1VwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUZmhpaWxubORsZEKAEAzwgh9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW INDANSULFAMIDNOE DERIVATIVES</title><source>esp@cenet</source><creator>VATANABE Toru ; KOSASA Takasi ; KHANADA Takakhisa ; ISIKAVA Yukio ; SAITO Minako ; KITA Joiti ; SORIMATI Keiiti ; TANAKA Tosiaki ; TERAMOTO Tetsuyuki ; KADZUTA Yudzi ; KHIGASIYAMA Khiroyuki</creator><creatorcontrib>VATANABE Toru ; KOSASA Takasi ; KHANADA Takakhisa ; ISIKAVA Yukio ; SAITO Minako ; KITA Joiti ; SORIMATI Keiiti ; TANAKA Tosiaki ; TERAMOTO Tetsuyuki ; KADZUTA Yudzi ; KHIGASIYAMA Khiroyuki</creatorcontrib><description>FIELD: chemistry.SUBSTANCE: new indansulfamidnye derivatives or their pharmaceutically acceptable salt , such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfonamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, are characterized by the effect of improving seizure severity index (score) in a murine model of kindling.EFFECT: compound or salt thereof are assumed as a medicament for the treatment of epilepsy.8 cl, 10 tbl, 3 dwg, 31 ex Новые индансульфамидные производные, или их фармацевтически приемлемая соль, такие как N-[(1S)-2,2,5,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, N-[(1S)-2,2,4,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, (+)-N-(2,2,4,6,7-пентафтор-2,3-дигидро-1H-инден-1-ил)сульфамид, характеризуются действием улучшения индекса тяжести припадка (балл) на мышиной модели киндлинга. Таким образом, соединения или их соль предполагаются в качестве лекарственного средства для лечения эпилепсии. 8 н.п. ф-лы, 10 табл., 3 ил., 31 пр.</description><language>eng ; rus</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170522&amp;DB=EPODOC&amp;CC=RU&amp;NR=2619937C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170522&amp;DB=EPODOC&amp;CC=RU&amp;NR=2619937C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VATANABE Toru</creatorcontrib><creatorcontrib>KOSASA Takasi</creatorcontrib><creatorcontrib>KHANADA Takakhisa</creatorcontrib><creatorcontrib>ISIKAVA Yukio</creatorcontrib><creatorcontrib>SAITO Minako</creatorcontrib><creatorcontrib>KITA Joiti</creatorcontrib><creatorcontrib>SORIMATI Keiiti</creatorcontrib><creatorcontrib>TANAKA Tosiaki</creatorcontrib><creatorcontrib>TERAMOTO Tetsuyuki</creatorcontrib><creatorcontrib>KADZUTA Yudzi</creatorcontrib><creatorcontrib>KHIGASIYAMA Khiroyuki</creatorcontrib><title>NEW INDANSULFAMIDNOE DERIVATIVES</title><description>FIELD: chemistry.SUBSTANCE: new indansulfamidnye derivatives or their pharmaceutically acceptable salt , such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfonamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, are characterized by the effect of improving seizure severity index (score) in a murine model of kindling.EFFECT: compound or salt thereof are assumed as a medicament for the treatment of epilepsy.8 cl, 10 tbl, 3 dwg, 31 ex Новые индансульфамидные производные, или их фармацевтически приемлемая соль, такие как N-[(1S)-2,2,5,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, N-[(1S)-2,2,4,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, (+)-N-(2,2,4,6,7-пентафтор-2,3-дигидро-1H-инден-1-ил)сульфамид, характеризуются действием улучшения индекса тяжести припадка (балл) на мышиной модели киндлинга. Таким образом, соединения или их соль предполагаются в качестве лекарственного средства для лечения эпилепсии. 8 н.п. ф-лы, 10 табл., 3 ил., 31 пр.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDwcw1X8PRzcfQLDvVxc_T1dPHzd1VwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfFBoUZmhpaWxubORsZEKAEAzwgh9A</recordid><startdate>20170522</startdate><enddate>20170522</enddate><creator>VATANABE Toru</creator><creator>KOSASA Takasi</creator><creator>KHANADA Takakhisa</creator><creator>ISIKAVA Yukio</creator><creator>SAITO Minako</creator><creator>KITA Joiti</creator><creator>SORIMATI Keiiti</creator><creator>TANAKA Tosiaki</creator><creator>TERAMOTO Tetsuyuki</creator><creator>KADZUTA Yudzi</creator><creator>KHIGASIYAMA Khiroyuki</creator><scope>EVB</scope></search><sort><creationdate>20170522</creationdate><title>NEW INDANSULFAMIDNOE DERIVATIVES</title><author>VATANABE Toru ; KOSASA Takasi ; KHANADA Takakhisa ; ISIKAVA Yukio ; SAITO Minako ; KITA Joiti ; SORIMATI Keiiti ; TANAKA Tosiaki ; TERAMOTO Tetsuyuki ; KADZUTA Yudzi ; KHIGASIYAMA Khiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2619937C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2017</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VATANABE Toru</creatorcontrib><creatorcontrib>KOSASA Takasi</creatorcontrib><creatorcontrib>KHANADA Takakhisa</creatorcontrib><creatorcontrib>ISIKAVA Yukio</creatorcontrib><creatorcontrib>SAITO Minako</creatorcontrib><creatorcontrib>KITA Joiti</creatorcontrib><creatorcontrib>SORIMATI Keiiti</creatorcontrib><creatorcontrib>TANAKA Tosiaki</creatorcontrib><creatorcontrib>TERAMOTO Tetsuyuki</creatorcontrib><creatorcontrib>KADZUTA Yudzi</creatorcontrib><creatorcontrib>KHIGASIYAMA Khiroyuki</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VATANABE Toru</au><au>KOSASA Takasi</au><au>KHANADA Takakhisa</au><au>ISIKAVA Yukio</au><au>SAITO Minako</au><au>KITA Joiti</au><au>SORIMATI Keiiti</au><au>TANAKA Tosiaki</au><au>TERAMOTO Tetsuyuki</au><au>KADZUTA Yudzi</au><au>KHIGASIYAMA Khiroyuki</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW INDANSULFAMIDNOE DERIVATIVES</title><date>2017-05-22</date><risdate>2017</risdate><abstract>FIELD: chemistry.SUBSTANCE: new indansulfamidnye derivatives or their pharmaceutically acceptable salt , such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfonamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, are characterized by the effect of improving seizure severity index (score) in a murine model of kindling.EFFECT: compound or salt thereof are assumed as a medicament for the treatment of epilepsy.8 cl, 10 tbl, 3 dwg, 31 ex Новые индансульфамидные производные, или их фармацевтически приемлемая соль, такие как N-[(1S)-2,2,5,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, N-[(1S)-2,2,4,7-тетрафтор-2,3-дигидро-1H-инден-1-ил]сульфамид, (+)-N-(2,2,4,6,7-пентафтор-2,3-дигидро-1H-инден-1-ил)сульфамид, характеризуются действием улучшения индекса тяжести припадка (балл) на мышиной модели киндлинга. Таким образом, соединения или их соль предполагаются в качестве лекарственного средства для лечения эпилепсии. 8 н.п. ф-лы, 10 табл., 3 ил., 31 пр.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2619937C2
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NEW INDANSULFAMIDNOE DERIVATIVES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T15%3A27%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VATANABE%20Toru&rft.date=2017-05-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2619937C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true